Clinical Pathways Based on Integrative Medicine in Chinese Hospitals Improve Treatment Outcomes for Patients with Acute Myocardial Infarction: A Multicentre, Nonrandomized Historically Controlled Trial

Table 2

Western medicine prescribing frequency.

Variable	Intervention group; (𝑛=197)	Historical control group; (𝑛=405)	𝜒^2	𝑃
Antiplatelet	197 (100)	402 (99)	—	1.00*
Low molecular weight heparin	197 (100)	362 (89)	—	0.00*
Statins	197 (100)	388 (96)	—	0.01*
β receptor blockers	160 (81)	320 (79)	0.12	0.72
ACE inhibitors; (or ARB)	163 (82)	324 (80)	0.64	0.42
Nitrate esters	138 (70)	276 (68)	0.07	0.79
Antiarrhythmic drugs	65 (33)	79 (20)	12.41	0.00

Values are given as number of patients (%).
*Using the exact probability method.
ACE: angiotensin-converting enzyme; ARB: angiotensin II receptor blocker.